-
3
-
-
0034697416
-
-
For the pyrrole-containing alkaloid Rhazinilam and related compounds synthesis and biological activity evaluation, see for example: (a) Banwell, M.; Edwards, A.; Smith, J.; Hamel, E.; Verdier-Pinard, P. J. Chem. Soc., Perkin Trans. 1 2000, 1497; (b) Pascal, C.; Dubois, J.; Guenard, D.; Gueritte, F. J. Org. Chem. 1998, 63, 6414; (c) David, B.; Sevenet, T.; Morgat, M.; Guenard, G.; Moisand, A.; Tollon, Y.; Thoison, O.; Wright, M. Cell Mobil. Cytoskel. 1994, 28, 317.
-
(2000)
J. Chem. Soc., Perkin Trans.
, vol.1
, pp. 1497
-
-
Banwell, M.1
Edwards, A.2
Smith, J.3
Hamel, E.4
Verdier-Pinard, P.5
-
4
-
-
0032483555
-
-
For the pyrrole-containing alkaloid Rhazinilam and related compounds synthesis and biological activity evaluation, see for example: (a) Banwell, M.; Edwards, A.; Smith, J.; Hamel, E.; Verdier-Pinard, P. J. Chem. Soc., Perkin Trans. 1 2000, 1497; (b) Pascal, C.; Dubois, J.; Guenard, D.; Gueritte, F. J. Org. Chem. 1998, 63, 6414; (c) David, B.; Sevenet, T.; Morgat, M.; Guenard, G.; Moisand, A.; Tollon, Y.; Thoison, O.; Wright, M. Cell Mobil. Cytoskel. 1994, 28, 317.
-
(1998)
J. Org. Chem.
, vol.63
, pp. 6414
-
-
Pascal, C.1
Dubois, J.2
Guenard, D.3
Gueritte, F.4
-
5
-
-
0028114165
-
-
For the pyrrole-containing alkaloid Rhazinilam and related compounds synthesis and biological activity evaluation, see for example: (a) Banwell, M.; Edwards, A.; Smith, J.; Hamel, E.; Verdier-Pinard, P. J. Chem. Soc., Perkin Trans. 1 2000, 1497; (b) Pascal, C.; Dubois, J.; Guenard, D.; Gueritte, F. J. Org. Chem. 1998, 63, 6414; (c) David, B.; Sevenet, T.; Morgat, M.; Guenard, G.; Moisand, A.; Tollon, Y.; Thoison, O.; Wright, M. Cell Mobil. Cytoskel. 1994, 28, 317.
-
(1994)
Cell Mobil. Cytoskel.
, vol.28
, pp. 317
-
-
David, B.1
Sevenet, T.2
Morgat, M.3
Guenard, G.4
Moisand, A.5
Tollon, Y.6
Thoison, O.7
Wright, M.8
-
6
-
-
0035733072
-
-
Varlamov A.V., Borisova T.N., Voskressensky L.G., Nsabimana B., Chernyshev A.I. Heterocyclic Commun. 7:2001;461.
-
(2001)
Heterocyclic Commun.
, vol.7
, pp. 461
-
-
Varlamov, A.V.1
Borisova, T.N.2
Voskressensky, L.G.3
Nsabimana, B.4
Chernyshev, A.I.5
-
7
-
-
0005119531
-
-
note
-
3 solutions, at 25°C using a Bruker WM 400 NMR spectrometer operating at 400 and 100 MHz, respectively. Mass-spectra were obtained by the EI technique (Finnigan-MAT 95 XL engine). General synthetic protocol: To a solution of 1 mmol of the THPP derivative in 10 ml of acetonitrile, 1.2 mmol of DMAD was added. The reaction mixture was stirred for 4-6 h at room temperature (TLC monitoring). Acetonitrile was evaporated under reduced pressure. The resulting residue was purified by column chromatography using ethyl acetate/hexane 1:1 mixture as eluent. The first fraction provided the corresponding pyrrolo[2,3-d]azocine derivatives as crystalline substances, which were recrystallized from ethyl acetate/hexane mixture.
-
-
-
-
8
-
-
0005119930
-
-
note
-
5: calcd C, 53.73; H, 5.26; N, 6.96; found C, 53.88; H, 5.65; N, 6.90.
-
-
-
-
9
-
-
0005195705
-
-
note
-
4: calcd C, 62.82; H, 5.80; N, 14.65; found C, 62.85; H, 5.65; N, 14.43.
-
-
-
-
10
-
-
0005119355
-
-
note
-
5: calcd C, 58.67; H, 4.70; N, 6.22; found C, 58.39; H, 4.72; N, 6.31.
-
-
-
-
14
-
-
33645733007
-
-
Borisova T.N., Stazharova I.A., Aliev A.E., Prostakov N.S., Varlamov A.V. Chem. Heterocyclic Compd. (Engl. Transl.). 27:1991;1105.
-
(1991)
Chem. Heterocyclic Compd. (Engl. Transl.)
, vol.27
, pp. 1105
-
-
Borisova, T.N.1
Stazharova, I.A.2
Aliev, A.E.3
Prostakov, N.S.4
Varlamov, A.V.5
|